2-(4-(1-(4-fluorophenyl)-1H-indol-3-yl)butyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline

ID: ALA3354882

Chembl Id: CHEMBL3354882

PubChem CID: 72722778

Max Phase: Preclinical

Molecular Formula: C29H31FN2O2

Molecular Weight: 458.58

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(cc1OC)CN(CCCCc1cn(-c3ccc(F)cc3)c3ccccc13)CC2

Standard InChI:  InChI=1S/C29H31FN2O2/c1-33-28-17-21-14-16-31(19-23(21)18-29(28)34-2)15-6-5-7-22-20-32(25-12-10-24(30)11-13-25)27-9-4-3-8-26(22)27/h3-4,8-13,17-18,20H,5-7,14-16,19H2,1-2H3

Standard InChI Key:  GWGRBNDXZUZCBZ-UHFFFAOYSA-N

Associated Targets(Human)

ABCB1 Tchem P-glycoprotein 1 (14716 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

SIGMAR1 Sigma-1 receptor (3326 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Sigmar1 Sigma opioid receptor (1607 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
C6 (2371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 458.58Molecular Weight (Monoisotopic): 458.2370AlogP: 6.17#Rotatable Bonds: 8
Polar Surface Area: 26.63Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.40CX LogP: 6.66CX LogD: 5.63
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.30Np Likeness Score: -0.86

References

1. Abate C, Pati ML, Contino M, Colabufo NA, Perrone R, Niso M, Berardi F..  (2015)  From mixed sigma-2 receptor/P-glycoprotein targeting agents to selective P-glycoprotein modulators: small structural changes address the mechanism of interaction at the efflux pump.,  89  [PMID:25462269] [10.1016/j.ejmech.2014.10.082]
2. Pati ML, Abate C, Contino M, Ferorelli S, Luisi R, Carroccia L, Niso M, Berardi F..  (2015)  Deconstruction of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline moiety to separate P-glycoprotein (P-gp) activity from σ2 receptor affinity in mixed P-gp/σ2 receptor agents.,  89  [PMID:25462276] [10.1016/j.ejmech.2014.11.001]
3. Xie F, Kniess T, Neuber C, Deuther-Conrad W, Mamat C, Lieberman BP, Liu B, Mach RH, Brust P, Steinbach J, Pietzsch J, Jia H.  (2015)  Novel indole-based sigma-2 receptor ligands: synthesis, structureaffinity relationship and antiproliferative activity,  (6): [10.1039/C5MD00079C]
4. Wan Y, Li Y, Yan C, Yan M, Tang Z..  (2019)  Indole: A privileged scaffold for the design of anti-cancer agents.,  183  [PMID:31536895] [10.1016/j.ejmech.2019.111691]

Source